Trial Profile
Efficacy and safety of combination chemotherapy with LBP or oxaliplatin plus capecitabine in locally advanced or metastatic gastric cancer: a randomized, controlled, multicenter clinical trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Jul 2018
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Lobaplatin (Primary) ; Oxaliplatin
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 10 Jul 2018 New trial record